NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCD E-083-2004-0-US-01 Peptide Mimotope Of Lipooligosaccaride From Moraxellea Catarralis As Vaccine Candidates US 60/531,239 Abandoned
NCI E-085-2003-2-CA-03 Cyanovirin Variant-Polymer Conjugates CA National Stage 2507904 Expired
NCI E-085-2003-2-KR-06 Cyanovirin Variant-Polymer Conjugates KR National Stage 10-2005-7011500 Expired
NCI E-085-2003-2-AU-07 Cyanovirin Variant-Polymer Conjugates AU National Stage 2003301122 Expired
NCI E-146-1999-0-US-03 Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutating the Framework Regions of the Fv to Lower the Isoelectric Point US National Stage 10/416,129 7521054 Expired PDF
NCI E-085-2003-2-EP-08 Cyanovirin Variant-Polymer Conjugates EP National Stage 03813787.3 Expired
NCI E-085-2003-2-DE-10 Cyanovirin Variant-Polymer Conjugates DE EP 03813787.3 Expired
NCI E-085-2003-2-US-02 Cyanovirin Variant-Polymer Conjugates US ORD 10/742,465 7267941 Expired PDF
NCI E-085-2003-2-PCT-01 Cyanovirin Variant-Polymer Conjugates PCT PCT COMB PCT/US03/40585 Expired
NCI E-085-2003-2-JP-04 Cyanovirin Variant-Polymer Conjugates JP National Stage 2005-502650 Expired
NIAID E-122-2001-0-IL-04 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof IL National Stage 159463 Abandoned
NIAID E-122-2001-0-US-05 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof US National Stage 10/481,180 7388089 Expired PDF
NCI E-136-1998-0-US-11 Novel Thiolesters and Uses Thereof US DIV 10/738,062 7625917 Abandoned PDF
NIDDK E-213-2001-2-US-02 Vitamin D Receptor Antagonists and Related Compositions and Methods of Use US National Stage 10/481,052 7361664 Abandoned PDF
NIDDK E-104-1989-0-US-14 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US CON 10/737,469 Abandoned
NCI E-243-2002-1-HK-07 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same HK EP 06103500.1 Abandoned
NCI E-243-2002-1-DE-09 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same DE EP 03814012.5 Abandoned
NCI E-243-2002-1-FR-10 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same FR EP 03814012.5 Abandoned
NCI E-243-2002-1-GB-11 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same GB EP 03814012.5 Abandoned
NCI E-243-2002-1-EP-06 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same EP National Stage 03814012.5 Abandoned
NCI E-243-2002-1-CA-04 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same CA National Stage 2510309 Abandoned
NCI E-243-2002-1-AU-03 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same AU National Stage 2003297155 Abandoned
NCI E-243-2002-1-PCT-01 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same PCT PCT COMB PCT/US03/39967 Abandoned
NCI E-243-2002-1-EP-12 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same EP DIV 3814012.5 Abandoned
NIAAA E-007-2003-1-US-01 Nutritional Supplements and Therapeutic Compositions Comprising (R)-3-Hydroxybutayrate Derivatives US 60/529,873 Abandoned
NCI E-321-2003-0-US-01 A Human Cytotoxic T-Lymphocyte Epitope And Its Agonist Epitope From The Non-variable Number of Tandem Repeat Sequence of Muc-1 US 60/529,329 Abandoned
NCI E-090-2003-0-US-01 IMMJNOGENIC PEPTIDES OF XAGE-1 US 60/529,025 Abandoned
NIDA E-223-2000-0-HK-09 Coil For Magnetic Stimulation HK National Stage 03108947.4 Expired
CC E-244-2000-1-US-02 Endoluminal Radiofrequency Cauterization System US DIV 10/733,225 7122033 Expired PDF
NCI E-058-2001-0-US-03 Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use US National Stage 10/480,693 Abandoned
NIAID E-115-2001-3-CN-05 MVA Expressing Modified HIV Envelope, Gag And Pol Genes CN National Stage 02809538.3 Abandoned
NCI E-321-2002-0-PCT-01 BASE, A New Cancer Gene, and Uses Thereof PCT PCT PCT/US03/39476 Expired
NCI E-231-1998-0-US-04 Lentivirus Vector System US DIV 10/731,988 7226780 Abandoned PDF
NCI E-265-2003-0-US-01 Methods for Inhibiting HIV And Other Viral Infection By Modulating Of Ceramide Metabolism US 60/528,411 Abandoned
NCI E-210-2002-0-US-01 Method for Ex-Vivo Selection and Expansion of Stimulus-Responding Primary Cells Using Selective Reversible Immortalization US 60/528,244 Abandoned
NHLBI E-259-2003-0-US-01 Methods for Suppressing an Immune Response or Treating a Proliferative Disorder US 60/528,340 Abandoned
NIAID E-188-2002-0-US-01 Identification of a Region of Merozoite Surface Protein 1 (MSP-1) Necessary for Protective Immunity US 60/503,076 Abandoned
NIAID E-066-2003-0-US-01 Identification of Chimpanzee FAB Fragments by Repertoire Cloning and Production of a Full-Length Humanized IgG1 Antibody Highly Efficient Neutralization of Dengue Type 4 Virus US 60/528,161 Abandoned
NHLBI E-185-2002-0-PCT-02 FITC-Encased Superparamagnetic Microparticles with a Shell of Inert Polystyrene and Di-Vinyl Benzene Coated with Activatable - COOH Groups PCT PCT PCT/US03/38820 Abandoned
NIDCD E-264-1997-0-US-15 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS US DIV 10/729,027 Abandoned
NCI E-207-2003-0-US-01 Catalytic Domains Of Beta(1,4)-Galactosyltransferase I Having Altered Metal Ion Specificity US 60/527,615 Abandoned
NIDCR E-227-2004-0-US-01 Truncated CMV Promoters and Vectors Containing Same US 60/527,146 Abandoned
NIDCR E-329-2003-0-US-01 Bovine Adeno-Associated Viral (BAAV) Vector And Uses Thereof US 60/526,786 Abandoned
NCI E-018-2004-0-US-01 Strand-Specific Amplification US 60/527,356 Abandoned
NCI E-231-1995-1-JP-13 EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION JP DIV 2003-406232 Abandoned
NCI E-259-1994-3-AU-09 RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST TUMOR-ASSOCIATED ANTIGENS AU DIV 2003266471 Abandoned
NCI E-099-1996-0-US-08 Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA) US DIV 10/725,373 7723096 Abandoned PDF
NIDCR E-080-2007-0-US-01 Method Of Preventing Survival Of Retrovirally Infected Cells And Of Inhibiting Formation Of Infectious Retrovirus US 60/526,110 Abandoned
NCI E-008-1998-0-US-05 Beta2 Microglobulin Fusion Proteins and High Affinity Variants US DIV 10/727,000 Abandoned
NCI E-079-1999-3-US-03 Methods, Devices, Arrays and Kits for Detecting and Analyzing Biomolecules US National Stage 10/432,423 6969615 Expired PDF